The National Cardiovascular Health Program
Active
- Assistance listing
- 93.426
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 23 $456,220,776 in federal obligations
Program facts
- Assistance type
-
- Cooperative Agreement
- Treasury account
-
- 75-0943-0-1-550
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services funds evidence-based cardiovascular disease prevention and management strategies addressing social determinants of health in high-burden populations through Assistance Listing 93.426, with the most recent grant awards issued on September 30, 2018.
The program supports state and local implementation of clinical and community interventions targeting diabetes prevention and management, hypertension control, and high cholesterol management in populations experiencing health disparities. Representative funded activities include expanding access to diabetes self-management education programs (DSMES) and CDC-recognized National Diabetes Prevention Programs (DPP); integrating pharmacists and community health workers into team-based care models; deploying blood pressure self-monitoring and electronic health record systems to identify and refer at-risk patients; and establishing community-clinical linkages connecting primary care with lifestyle intervention programs. The Nebraska Department of Health and Human Services received $12.7 million to expand DSMES coverage and improve medication management through pharmacist engagement. Florida was awarded $23.6 million to implement diabetes prevention strategies using community health workers and evidence-based quality measures. Georgia received the largest award at $29.8 million for statewide diabetes and CVD prevention infrastructure.
All 23 awards in the portfolio are Cooperative Agreements with 1- to 5-year periods of performance, after which projects may continue non-competitively contingent on satisfactory progress and federal interest. The CDC awarded 23 grants totaling $456.2 million in federal obligations (combined federal and non-federal total of $462.7 million) as of September 30, 2018. Recent grant opportunities closed in mid-2023: CDC-RFA-DP-23-0004 (due April 25, 2023) solicited applications from state governments and other entities to implement CVD prevention strategies addressing social determinants; CDC-RFA-DP-23-0005 (due May 23, 2023) expanded eligible applicants to include higher education institutions, nonprofits, local governments, and tribal organizations for health system interventions targeting hypertension and hypercholesterolemia control. No currently open solicitation is present in the source.
Objective and description
- Objective
This program supports extensive scientific evidence, links nonmedical factors, including systemic racism and the lack of economic opportunities, with poor health outcomes and increased mortality rates, all of which are preventable. Factors such as po
- Description
This program aims to implement and evaluate evidence-based strategies contributing to the prevention and management of CVD in populations disproportionately at risk. Given the importance of health equity, this program addresses social and economic factors to help communities and health systems respond to social determinants present in their communities to offer those at risk of or burdened with CVD the best health outcomes possible.
Eligibility
- Applicant eligibility
State Governments or their Bona Fide Agents (includes the District of Columbia) are eligible
- Beneficiary eligibility
Beneficiaries of this program include: State, Local, Individual/Family, Minority Group, Anyone/General Public, Black American, American Indian, Spanish Origin, Oriental, Other Nonwhite, Women, Handicapped, Physically Afflicted, Senior Citizen, Rural
- Uses of assistance
Funds for this program are to be used to implement and evaluate evidence-based strategies to address the challenges and systemic barriers that contribute to prevention and management of cardiovascular disease and diabetes in high-burden populations.
- Length and time phasing of assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.
How to apply
- Preapplication coordination
Refer to the NOFO posted on grants.gov for additional information.
- Criteria for selecting proposals
Applications will be evaluated on the review criteria described in the Notices of Funding Opportunity (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.
- Award procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public.
- Deadlines
Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.
- Time to approval or disapproval
Applications will be evaluated and approved or disapproved within 180 days of submission to the Federal Agency
- Renewals
Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Grant opportunities
Grant awards
Latest 10 of 23 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Department Of State Health Services | $28,132,602 | 6% |
| 2 | California Department Of Public Health | $27,800,584 | 6% |
| 3 | State Of Georgia Department Of Public Health | $27,379,904 | 6% |
| 4 | Michigan Department Of Health And Human Services | $25,184,822 | 6% |
| 5 | Florida Department Of Health | $23,591,112 | 5% |
| 6 | Department Of Public Health Illinois | $23,236,448 | 5% |
| 7 | Ohio Department Of Health | $23,070,500 | 5% |
| 8 | North Carolina Department Of Health & Human Services | $21,305,984 | 5% |
| 9 | Virginia Department Of Health | $20,299,880 | 4% |
| 10 | Washington State Department Of Health | $20,288,886 | 4% |
10 of 23 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2024 | $88,243,962 |
| FY2023 | $163,896,543 |
| FY2022 | $208,891,178 |
| FY2021 | $110,000,000 |
| FY2020 | $245,138,840 |
| FY2019 | $358,791,623 |
| FY2018 | $90,000,002 |
Quick answers
What is Assistance Listing 93.426?
Assistance Listing 93.426 is The National Cardiovascular Health Program, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for The National Cardiovascular Health Program?
Its CFDA number is 93.426: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.426 awarded?
23 grant awards under 93.426 have obligated $456,220,776 in federal funds to 23 recipients.
Who receives the most funding from 93.426?
The recipients obligated the most under The National Cardiovascular Health Program are Department Of State Health Services ($28,132,602), California Department Of Public Health ($27,800,584) and State Of Georgia Department Of Public Health ($27,379,904).
Are there open grant opportunities under 93.426?
No opportunity listed under 93.426 is open now. The latest, The National Cardiovascular Health Program, was posted on August 3, 2022.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program